<qa>  What STUDY OF DACLIZUMAB HIGH YIELD PROCESSSAFETY AND EFFICACY EXTENSION STUDY OF DACLIZUMAB HIGH YIELD PROCESS DAC HYP IN PARTICIPANTS WITH MULTIPLE SCLEROSIS WHO HAVE COMPLETED STUDY 205MS201 NCT00390221 TO TREAT RELAPSING-REMITTING MULTIPLE SCLEROSIS: 